Characteristics of patients with MGUS-L and non–MGUS-L MM in the test set
| Characteristics . | MGUS-L, % . | Non-MGUS-L, % . | P . |
|---|---|---|---|
| n | 55 | 159 | — |
| B2M ≥ 3.0 mg/L* | 42 | 63 | .006 |
| Cytogenetic abnormalities | 16 | 36 | .006 |
| LDH ≥ upper limit of normal | 7 | 23 | .012 |
| Subgroups with poor prognosis† | 19 | 41 | .018 |
| Characteristics . | MGUS-L, % . | Non-MGUS-L, % . | P . |
|---|---|---|---|
| n | 55 | 159 | — |
| B2M ≥ 3.0 mg/L* | 42 | 63 | .006 |
| Cytogenetic abnormalities | 16 | 36 | .006 |
| LDH ≥ upper limit of normal | 7 | 23 | .012 |
| Subgroups with poor prognosis† | 19 | 41 | .018 |